Spero Therapeutics

Pharma

Analyst says FDA appears to be 'raising the regulatory bar'

Is the FDA tightening the screws on drug approvals? Analysts at Evercore ISI believe so based on companies receiving recent notices of "deficiencies."

Kevin Dunleavy Apr 13, 2022 10:20am